GENE ONLINE|News &
Opinion
Blog

Novartis
News Flash Biotech Stocks
Biotech Stocks Rise Following Federal Reserve Rate Outlook
2025-03-21
Deals Cardiovascular
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GO Green Sustainability
Pharma’s Growing (R)evolution: Sustainability and Innovations Shaping the Industry
2025-01-07
Deals Oncology Market
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Ranking & Reports NovartisQ2 Report
Novartis Achieves 11% Sales Growth with Strong Performance in Heart Failure, Immune Drugs, and R&D in Q2
2024-08-06
Trials & Approvals CAR-T therapyCAR T-cell Therapy
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
JPM 2024 Global EventsDrug Price NegotiationDigital Healthcare
JPM 2024: More Noteworthy Industry Stories and Updates of Long-rumored Cytokinetics Acquisition
2024-01-15
JPM 2024 JPMJP Morgan 2024
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
2024-01-10
Asia-Pacific partnershipBiosimilar
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
Feature FDA ApprovalGene and Cell Therapy
GeneOnline’s Weekly News Highlights: July 31-Aug 4
2023-08-07
M&A Neuromuscular Disorder
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
Special biomedicalHealthcare
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
M&A acquisitionNovartis
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Partnerships Novartis
Novartis Lays Down $40 Million for 3BP’s FAP-Targeting Oncology Tech
2023-04-24
Trials & Approvals Breast Cancer
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
1 2 3 … 7
LATEST
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
READ MORE
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top